Notably, systematic neuropathological analyses have revealed that 95–97% of patients with ALS and approximately 50% of patients with FTD share the presence of cytoplasmic TARDBP inclusions (Neumann et al., 2006; Hasegawa et al., 2008). Here, TARDBP is linked to amyotrophic lateral sclerosis.